article thumbnail

GeneSight® Mental Health Monitor Results

Myriad Genetics

  Whitnee Brown, a PMHNP and Doctor of Nursing Practice in Birmingham, Alabama, and her patient Lisa Roberts of Huntsville, shared their stories in support of the survey results, which can be viewed here.  In 2003, he was the co-winner of the AAPOR Innovator’s award for helping to establish the Standard’s Definitions Manual.

article thumbnail

What to know about High Blood Pressure (Hypertension)

Georgetown Pediatrics & Family Medicine

The Joint National Committee 2003 defines hypertension as systolic of 140 mmHg and higher or diastolic 90 mmHg and higher. Many patients do not recognize elevated blood pressure as it can be subtle such as intermittent vision change or headaches. What are some signs and symptoms of Hypertension?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

To List or Not to List; That is the Question – The FTC Signals the Potential for Greater Scrutiny of Patent Information Submissions to FDA

FDA Law Blog

The FTC expressed concern that patent listings that do not meet the statutory criteria undermine the competitive process, may disincentivize investment in developing generic and follow-on products, and reduce patient access to more affordable drugs thereby increasing costs to the healthcare system.

article thumbnail

Lead, follow or get out of the way

Physician's Practice

Reynolds Blog Article Innovative medical practices thrive by embracing change, prioritizing patient care and learning from setbacks to enhance success and satisfaction. Neil Baum, MD Successful practices do not follow others; rather, they make their own paths and follow their own pathways and agendas.

article thumbnail

A New Report Takes an Evidence-Based Approach to Analyzing the BLOCKING Act

FDA Law Blog

The net effect will be that brand-name prices will remain higher for longer, and there will be fewer generic drugs available to patients. Section I provides data demonstrating the importance of the 180-day exclusivity incentive to generic competition. The new action-packed and data-driven report has three primary sections.

article thumbnail

Surely You Must be Kidding, PTO?!? “No, and Don’t Call Me Shirley!” – The Seemingly Slapstick (But Yet Unfunny) World of Recent Patent Term Extension Decisions (PART 1)

FDA Law Blog

For years after the enactment of the Hatch-Waxman Amendments the PTO interpreted the PTE statute to permit multiple PTEs, provided there are separate, but not necessarily different, regulatory review periods. 2003) , and Biogen lnt’l v. See Lourie, Patent Term Restoration: History, Summary, and Appraisal, 40 Food, Drug, and Cosm.

article thumbnail

Episode 232: Anti-Racism in Medicine Series – Episode 15 – Housing is Health: Racism and Homelessness – Clinician + Community Perspectives

The Clinical Problem Solvers

Our guests remind us to ask our patients about their housing status using non-judgmental and non-stigmatizing language. If we do not know the housing status of our patients, then we do not know one of the most fundamental things that is going to affect their health and wellbeing. 2. Can you refer your patient there? 3.